Biggest News Aggregation in the World
📰 Positive Phase News

Positive Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Positive Phase. Real-time updates on events, politics, business and more.

Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC)

- New Positive Phase 2 Results in Metastatic Triple Negative Breast Cancer Indicate That Use of Trilaciclib in Combination with a TROP2 ADC May Be Associated with Improved Median OS Compared to...
Los Angeles United States Lasika Seneviratne Raj Malik Sacituzumab Govitecan European Society For Medical Oncology

Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC) - G1 Therapeutics (NASDAQ:GTHX)

- New Positive Phase 2 Results in Metastatic Triple Negative Breast Cancer (mTNBC) Indicate That Use of Trilaciclib in Combination with a TROP2 ADC May Be Associated with Improved Median OS Compared to Historical Data
United States Los Angeles Raj Malik Lasika Seneviratne Sacituzumab Govitecan European Society For Medical Oncology

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

El Niño is ramping up for the winter, what does it mean for Central Illinois?

Peoria, Ill. (WMBD) — After a rare triple dip La Niña, El Niño is back and is expected to persist well into 2024. So how might this impact our upcoming winter? Let’s go back and take a look at some past El Niño winters and see if we can identify any trends. What is the […]
United States Great Lakes Illinois River Climate Prediction Center Southern Oscillation Positive Phase

© 2023 Tonix Pharmaceuticals Holding Corp. INVESTOR PRESENTATION NASDAQ: TNXP Version P04 88 September 25 , 2023 (Doc 1321 ) - Form 8-K -September 25, 2023 at 04:40 pm EDT

T ianeptine - tianeptine 1 Stablon. Summary of product characteristics. Les Laboratoires Servier Industrie ; 2014. 2 PubChem. Accessed November 10, 2022....
United States Dapirolizumab Letolizumab Aglycosyl Ruplizumab Cyclobenzaprine Protectic Clin Rheumatol Zembrace Symtouch Edward Jenner

Sanofi - Aventis Groupe: Press Release: Positive Phase 2 data of novel investigational anti-CD40L antibody frexalimab show significantly reduced disease activity in relapsing multiple sclerosis

Positive Phase 2 data of novel investigational anti-CD40L antibody frexalimab show significantly reduced disease activity in relapsing multiple sclerosis Frexalimab met primary
France General Sally Bain Eva Schaefer Jansen Tarik Elgoutni Erik Wallstr Corentine Driancourt

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science